Acadia

3 Plausible Buyout Scenarios Within Biotech
Seeking Alpha
Tue, 07/5/16 - 10:20 am
biotech
Acadia
AstraZeneca
Allergan
Biogen
Teva Pharmaceutical
Biomarin
Incyte
Ironwood
Medivation
Pfizer
Relypsa
Synergy Pharmaceuticals
M&A
Pfizer, Biogen May Eye Acadia for Takeover
Bidness, ETC
Fri, 05/20/16 - 10:27 am
Pfizer
Biogen
Acadia
M&A
U.S. approves first drug for psychosis linked to Parkinson's
Yahoo/Reuters
Sat, 04/30/16 - 10:42 am
Parkinson's Disease Psychosis
FDA
Acadia
Nuplazid
Acadia: Approval Likely For Parkinson's Disease Psychosis Drug
Seeking Alpha
Wed, 04/13/16 - 11:56 am
Acadia
Parkinson's Disease Psychosis
pimavanserin
Top 6 Biopharma Movers of the Past Week
24/7 Wall St
Mon, 04/4/16 - 07:56 am
Genocea Biosciences
OPKO Health
ContraVir
Inovio
Acadia
Apricus Biosciences
This Could Be the Next Big Pharma Buyout
Motley Fool
Sun, 04/3/16 - 10:56 am
Big Pharma
M&A
JNJ
Geron
Acadia
Jazz Pharmaceuticals
Bluebird Bio
Kite Pharma
Why Biogen Should Acquire ACADIA Pharmaceuticals
Bidness, ETC
Thu, 03/31/16 - 10:06 am
Biogen
Acadia
M&A
Parkinson's Disease Psychosis
Nuplazid
FDA advisers back first drug intended to treat psychotic symptoms of Parkinson's disease
Yahoo/AP
Tue, 03/29/16 - 10:24 pm
FDA
Parkinson's Disease Psychosis
Acadia
advisory panels
pimavanserin
It could reduce hallucinations, but at what cost? New Parkinson’s drug raises questions
Stat
Tue, 03/29/16 - 11:09 am
Parkinson's Disease Psychosis
Nuplazid
Acadia
FDA's internal review of Acadia's Parkinson's drug raises safety, benefit concerns
Fierce Biotech
Sat, 03/26/16 - 12:41 pm
FDA
Acadia
Parkinson's Disease Psychosis
Nuplazid
FDA staff backs Acadia's drug to treat psychosis associated with Parkinson's disease
Yahoo/Reuters
Fri, 03/25/16 - 09:37 am
FDA
Acadia
Parkinson's Disease Psychosis
Nuplazid
5 Key FDA Decisions Expected in March
24/7 Wall St
Mon, 03/14/16 - 10:02 am
FDA
Rayaldee
OPKO Health
Nuplazid
Acadia
abaloparatide
Radius Health
pegvaliase
Biomarin
ALD403
Alder Biopharmaceuticals
3 Upcoming FDA Decisions We're Most Excited About
Motley Fool
Sat, 02/13/16 - 09:25 am
FDA
Acadia
Intercept Pharma
Clovis Oncology
Nuplazid
OCA
rociletinib
Should AbbVie, Inc. Buy Acadia Pharmaceuticals to Help Fight Parkinson's Disease?
Motley Fool
Wed, 04/8/15 - 10:46 am
AbbVie
Acadia
Parkinson's Disease
Nuplazid
This Exciting Biotech Isn't Built to Last
Motley Fool
Thu, 03/19/15 - 11:10 am
Acadia
Acadia Drug Is Delayed Again as CEO Announces Retirement
TheStreet.com
Wed, 03/11/15 - 08:28 pm
Acadia
Nuplazid
Parkinson's Disease Psychosis
Acadia Surges as Canceled Events Lead to Deal Speculation
Bloomberg
Wed, 03/11/15 - 10:44 am
Acadia
M&A
The Coming Boom In Brain Medicines
Forbes
Wed, 02/11/15 - 09:33 am
Yumanity Therapeutics
SAGE Therapeutics
Acadia
Naurex
brain research
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1
TheStreet.com
Fri, 01/9/15 - 09:17 am
Celgene
Gilead Sciences
Express Scripts
Biogen Idec
Amicus Therapeutics
NPS Pharmaceuticals
Sanofi
Acadia
Orexigen
Pharmacyclics
Vertex Pharmaceuticals
Acadia surges after nabbing 'breakthrough' title for late-stage Parkinson's drug
Fierce Biotech
Tue, 09/2/14 - 11:19 am
Parkinson's Disease
Acadia
pimavanserin

Pages